Effects of an Oral Glucose Load on Serum Immunoreactive Insulin, Free Fatty Acid, Growth Hormone and Blood Sugar Levels in Young and Elderly Subjects*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 21, Iss. 10, 1973-10 ,pp. : 433-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats

By Iwase Masanori   Uchizono Yuji   Nohara Sakae   Sasaki Nobuhiro   Sonoki Kazuo   Iida Mitsuo  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 1, 2009-02 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite

Exendin4, a glucagonlike peptide1 receptor agonist, modulates hepatic fatty acid composition and ∆5desaturase index in a murine model of nonalcoholic steatohepatitis

By        

International Journal of Molecular Medicine, Vol. 34, Iss. 3, 2014-01 ,pp. : 782-787

Spandidos Publications

Access to resources Recommend Favorite

Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 4, 2015-04 ,pp. : 414-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment with PPARδ agonist alleviates non-alcoholic fatty liver disease by modulating glucose and fatty acid metabolic enzymes in a rat model

By                  

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 767-775

Spandidos Publications

Access to resources Recommend Favorite